-
Electronic (PDF)
-
Site License
-
Enterprisewide
Pain Therapeutics, Inc. (PTIE) - Financial and Strategic SWOT Analysis Review
GlobalData, September 2011, Pages: 39
Pain Therapeutics, Inc. (PTIE) - Financial and Strategic SWOT Analysis Review
Summary
Pain Therapeutics, Inc. (Pain Therapeutics) is a biopharmaceutical company that develops novel drugs.
The company provides drugs primarily for moderate or severe chronic pain, Metastatic melanoma and Hemophilia. Currently, the company has three drug candidates in clinical trials and one drug candidate in preclinical stage, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia. The company has a strategic alliance with King to develop REMOXY, a painkiller designed to reduce risks of unintended use; and other abuse-resistant painkillers. Pain Therapeutics is headquartered at Austin in Texas, the US.
Pain Therapeutics, Inc. Key Recent Developments
Apr 27, 2011: Pain Therapeutics Reports Net Loss Of $0.2m For Q1 2011
Feb 03, 2011: Pain Therapeutics Reports Net Loss Of $9.2 Million For Q4 2010
Nov 02, 2010: Pain Therapeutics Receives $2 Million Research Grant
Oct 28, 2010: Pain Therapeutics Reports Net Loss Of $1 Million For Q3 2010
Jul 28, 2010: Pain Reports Net Loss Of $0.8 Million For Q2 2010
This comprehensive SWOT profile of Pain Therapeutics, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
Pain Therapeutics, Inc. - Key Facts
Pain Therapeutics, Inc. - Key Employees
Pain Therapeutics, Inc. - Key Employee Biographies
Pain Therapeutics, Inc. - Major Products and Services
Pain Therapeutics, Inc. - Pharmaceutical Pipeline Products Data
Pain Therapeutics, Inc., Pipeline Products by Therapy Area
Pain Therapeutics, Inc., Pipeline Products by Development Phase
Pain Therapeutics, Inc. - History
Pain Therapeutics, Inc. - Company Statement
Pain Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Pain Therapeutics, Inc. - Business Description
Pain Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Pain Therapeutics, Inc. - Strengths
Strength - Strategic Alliances and Collaborations
Strength - Focused Research and Development
Strength - Technological Focus
Weakness - Dependence on the Third Party Manufacturers
Weakness - Capital Deficit
Weakness - Lack of Marketing or Distribution Capabilities
Weakness - Declining Operating Margin
Opportunity - Focus on Growing Therapeutic Segments
Opportunity - Population Trends
Opportunity - Growing Healthcare Market in the US
Threat - Uncertain R&D Outcomes
Threat - Government Regulations
Threat - Intense Competition
Pain Therapeutics, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pain Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Pain Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Pain Therapeutics, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 27, 2011: Pain Therapeutics Reports Net Loss Of $0.2m For Q1 2011
Feb 03, 2011: Pain Therapeutics Reports Net Loss Of $9.2 Million For Q4 2010
Nov 02, 2010: Pain Therapeutics Receives $2 Million Research Grant
Oct 28, 2010: Pain Therapeutics Reports Net Loss Of $1 Million For Q3 2010
Jul 28, 2010: Pain Reports Net Loss Of $0.8 Million For Q2 2010
Apr 28, 2010: Pain Therapeutics Reports Net Loss Of $1 Million For Q1 2010
Jan 28, 2010: Pain Therapeutics Reports Net Loss Of $0.3 Million For Q4 2009
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Watson Pharmaceuticals, Inc.
Purdue Pharma L.P.
Ortho-McNeil Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Alternative technologies
Elkins-Sinn Inc
Endo Pharmaceuticals Holdings Inc.
Cephalon, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
